Home
Home

patents

Sanofi's CEO On The New York Times' Criticism Of Drug Prices And Surviving The Patent Cliff

Sanofi's CEO On The New York Times' Criticism Of Drug Prices And Surviving The Patent Cliff
Forbes

Lipitor's Patent Expiration: How Much Will It Impact Pfizer's Revenue And Earnings In 2012?

Lipitor's Patent Expiration: How Much Will It Impact Pfizer's Revenue And Earnings In 2012?
Seeking Alpha

India Patent Authority Has Big Pharma Worried

India Patent Authority Has Big Pharma Worried
Connecticut Law Tribune, CT

United States : White & Case Secures Victory in AndroGel Antitrust Class Actions [TendersInfo (India)]

United States : White & Case Secures Victory in AndroGel Antitrust Class Actions
equities.com

Five More Years of Patent Protection, and Revenue, for Spectrum Pharmaceuticals

Five More Years of Patent Protection, and Revenue, for Spectrum Pharmaceuticals
Yahoo/Reuters

Merck Shrugs off Patent Worries, Eyes China

Merck Shrugs off Patent Worries, Eyes China
Motley Fool

Bristol-Myers Squibb - Between Patent Deadlines And Revenue Shifts

Bristol-Myers Squibb - Between Patent Deadlines And Revenue Shifts
Seeking Alpha

POZEN patents upheld in Treximet patent litigation appeal

POZEN patents upheld in Treximet patent litigation appeal
The Fly on the Wall

[video]Pfizer's Life After Lipitor: A 20% Rally Perhaps?

[video]Pfizer's Life After Lipitor: A 20% Rally Perhaps?
Bloomberg

ACLU Asks Supreme Court To Review Gene Patents

ACLU Asks Supreme Court To Review Gene Patents
Pharmalot